Alterations of p53 and c-myc in the clonal evolution of malignant lymphoma.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Blood

• Publication date

  1994-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V83.2.452.452PMID 8286743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wild‐type p53 adopts a ‘mutant’‐like conformation when bound to DNA.

  1993cited by this paper
• p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy.

  1993cited by this paper
• Mutations of p53 gene and their relation to disease progression in B-cell lymphoma.

  1992cited by this paper
• Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells.

  1992cited by this paper
• Constitutive expression of p53 protein in enriched normal human marrow blast cell populations.

  1992cited by this paper
• A human lymphoma cell line with multiple immunoglobulin rearrangements.

  1992cited by this paper
• myc family oncogenes in the development of normal and neoplastic cells.

  1991cited by this paper
• p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

  1991cited by this paper
• p53 in chronic myelogenous leukemia in acute phase.

  1991cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• p53 is frequently mutated in Burkitt's lymphoma cell lines.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

  1990cited by this paper
• Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2

  1990cited by this paper
• p53: oncogene or anti-oncogene?

  1990cited by this paper
• Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemia.

  1990cited by this paper
• p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

  1990cited by this paper
• Frequency and structure of p53 rearrangements in human osteosarcoma.

  1990cited by this paper
• p53 mutations in colorectal cancer.

  1990cited by this paper
• Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.

  1989cited by this paper
• Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia.

  1989cited by this paper
• p53: a frequent target for genetic abnormalities in lung cancer.

  1989cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene.

  1988cited by this paper
• Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30].

  1988cited by this paper
• The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor.

  1987cited by this paper
• Primary structure polymorphism at amino acid residue 72 of human p53

  1987cited by this paper
• Rearrangement of the p53 gene in human osteogenic sarcomas.

  1987cited by this paper
• Characterization of the human p53 gene

  1986cited by this paper
• Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment

  1986cited by this paper
• Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

  1986cited by this paper
• Evolution of tumours and the impact of molecular oncology

  1985cited by this paper
• Molecular basis of human B cell neoplasia.

  1985cited by this paper
• Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus

  1985cited by this paper
• A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains

  1984cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper
• Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

  1982cited by this paper
• Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).

  1982cited by this paper
• Monoclonal antibodies specific for simian virus 40 tumor antigens

  1981cited by this paper
• p 53 mutations in colorectal cancer ( immunohistokogy / polymerase chain reaction / chemical mismatch cleavage / adenocarcinoma )

  year unknowncited by this paper

• The Value of Immunohistochemistry of P53 and Ki67 in Non-Hodgkin’s Lymphoma

  2019cites this paper
• The Value of Immunohistochemistry of P 53 and Ki 67 in Non-Hodgkin ’ s Lymphoma Dr .

  2019cites this paper
• Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.

  2018cites this paper
• Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia

  2017cites this paper
• Radiation induced bystander effect and DNA damage.

  2014cites this paper
• 16 – Hodgkin Disease and Non-Hodgkin Lymphomas

  2010cites this paper
• Technical and biological issues relevant to cell typing with aptamers.

  2009cites this paper
• Progressive tumor growth-associated altered tumor microenvironment: implications in a tumor stage-dependent modulation in survival of a murine T cell lymphoma

  2009cites this paper
• p21(WAF1)-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy

  2007cites this paper
• DNA strand break associated bystander effect (DSB-ABE) is linked to gene mutations in naive cells and indicates the involvement of a MAPK pathway.

  2007cites this paper
• Genetic Alterations ofp 53 and ras Genes in 1 , 3-Butadiene-and 2 ' , 3 '-Dideoxycytidine-inducedLymphomas 1

  2006cites this paper
• Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes

  2005cites this paper
• p53, Mdm2, and c‐Myc overexpression is associated with a poor prognosis in aggressive non‐Hodgkin's lymphomas

  2001cites this paper
• Molecular Analysis of Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of Ocular Adnexa

  2001cites this paper
• p53 alterations in human leukemia–lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?

  2000cites this paper
• Antisense therapeutics in chronic myeloid leukaemia: the promise, the progress and the problems

  2000cites this paper
• [Biological principles for multimodal therapy approaches].

  2000cites this paper
• Dosisintensität und Zelltod

  1999cites this paper
• p53 gene Mutations and rearrangements in non‐Hodgkin's lymphoma

  1999cites this paper
• Proliferation, C-myc, and cyclin D1 expression in diffuse alveolar damage: potential roles in pathogenesis and implications for prognosis.

  1999cites this paper
• Pooled analysis of p53 mutations in hematological malignancies

  1998cites this paper
• Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog

  1998cites this paper
• Genetic alterations of p53 and ras genes in 1,3-butadiene- and 2',3'-dideoxycytidine-induced lymphomas.

  1997cites this paper
• Functional and Physical Consequence of Human Immunodefficiency Virus Transactivator TAT Interaction with Human Cell Cycle Regulator p53

  1997cites this paper
• p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.

  1996cites this paper
• Non-pyothorax-associated primary pleural lymphoma with complex karyotypic abnormalities.

  1996cites this paper
• Immunomodulatory Mechanisms Mediated by Sex Hormones in Rheumatoid Arthritis a

  1996cites this paper
• The role of p53 in malignancy.

  1996cites this paper
• p53 exon 5 mutations in two cases of leukemic mantle cell lymphoma.

  1996cites this paper
• Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.

  1996cites this paper
• p53 in lymphomas of mucosal-associated lymphoid tissues.

  1996cites this paper
• p53 oncoprotein expression in cutaneous lymphoproliferations.

  1995cites this paper
• Estrogens, the immune response and autoimmunity.

  1995cites this paper
• p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.

  1995cites this paper